32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody

Title
32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 101, Issue 6, Pages 1222-1227
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2016-07-04
DOI
10.1097/tp.0000000000001330

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started